Robotic-assisted aortic valve replacement for severe narrowing
Part of Heart & circulation clinical trials.
This trial tests a robotic system that helps doctors replace a narrowed aortic valve without open-heart surgery (TAVR). It may make the procedure more precise and safer for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older
- You have severe aortic stenosis (your heart's aortic valve is narrowed)
- Your heart team has said you are a good candidate for TAVR (a procedure to replace the valve without open-heart surgery)
- You have not had a previous aortic valve replacement
- You have not had a recent heart attack or stroke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new robotic system that helps doctors perform a minimally invasive heart valve replacement. It may offer a more precise way to treat severe aortic stenosis.
This trial tests a new type of aortic valve replacement that can be inserted without open-heart surgery. It's designed for people with severe aortic stenosis who are not suitable for a standard operation.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial tests whether a robot can safely help doctors perform TAVR, a procedure to replace a narrowed heart valve. The robot assists the doctor during the procedure, which may improve precision and outcomes.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
Hear when a new Aortic Stenosis Treated With TAVI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.